Restarting smoking after discharge from clozapine inpatient initiation: Elevated rehospitalization rates smoking & clozapine rehospitalization.
Saved in:
| Title: | Restarting smoking after discharge from clozapine inpatient initiation: Elevated rehospitalization rates smoking & clozapine rehospitalization. |
|---|---|
| Authors: | So, Ryuhei (AUTHOR), Tsukahara, Masaru (AUTHOR), Nakajima, Shinichiro (AUTHOR), Takeuchi, Hiroyoshi (AUTHOR) |
| Source: | Psychiatry & Clinical Neurosciences. Apr2024, Vol. 78 Issue 4, p259-260. 2p. |
| Subjects: | Clozapine, Patient readmissions, Smoking statistics |
| Abstract: | This article discusses the impact of smoking on relapse rates in patients with treatment-resistant schizophrenia (TRS) who are taking clozapine, a medication commonly used to treat TRS. The study was conducted in Japan, where a smoking ban was implemented in psychiatric hospitals. The researchers found that patients who resumed smoking after discharge had a higher risk of rehospitalization compared to those who did not smoke. These findings suggest that clinicians should consider measuring clozapine blood concentrations before and after discharge, especially in smokers, and adjust the clozapine dose accordingly. Further research is needed to validate these findings and develop clinical guidelines for monitoring and adjusting clozapine doses. [Extracted from the article] |
| Copyright of Psychiatry & Clinical Neurosciences is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | This article discusses the impact of smoking on relapse rates in patients with treatment-resistant schizophrenia (TRS) who are taking clozapine, a medication commonly used to treat TRS. The study was conducted in Japan, where a smoking ban was implemented in psychiatric hospitals. The researchers found that patients who resumed smoking after discharge had a higher risk of rehospitalization compared to those who did not smoke. These findings suggest that clinicians should consider measuring clozapine blood concentrations before and after discharge, especially in smokers, and adjust the clozapine dose accordingly. Further research is needed to validate these findings and develop clinical guidelines for monitoring and adjusting clozapine doses. [Extracted from the article] |
|---|---|
| ISSN: | 13231316 |
| DOI: | 10.1111/pcn.13629 |
